The rate of the founder Jewish mutations in BRCA1 and BRCA2 in prostate cancer patients in Israel

Схожие документы

• The rate of the 6174delT founder Jewish mutation in BRCA2 in patients with non-colonic gastrointestinal tract tumours in Israel
  по: Figer, A, et al.
  Опубликовано: (2001)
• Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer
  по: Hamel, Nancy, et al.
  Опубликовано: (2003)
• The Jewish Ashkenazi founder mutations in the BRCA1/BRCA2 genes are not found at an increased frequency in Ashkenazi patients with prostate cancer.
  по: Hubert, A, et al.
  Опубликовано: (1999)
• Modeling the Probability That Ashkenazi Jewish Women Carry a Founder Mutation in BRCA1 or BRCA2
  по: Hopper, John L., et al.
  Опубликовано: (1999)
• Identifying Ashkenazi Jewish BRCA1/2 founder variants in individuals who do not self-report Jewish ancestry
  по: Tennen, Ruth I., et al.
  Опубликовано: (2020)